SCHEMBL14467201

SCHEMBL14467201

O=S(=O)(c1ccccc1)c1cc2cc(-c3ccc(-c4ccc(-c5cc6cc(-c7ccccc7)ncc6s5)s4)s3)sc2cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.37
PIK3C3 Q8NEB9 1/20 0.37
HTR1A P08908 1/20 0.37
HTR2A P28223 1/20 0.37
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37
AURKA O14965 1/20 0.36
AKT1 P31749 3/20 0.35
MTOR P42345 1/20 0.35
AGTR1 P30556 1/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
NPSR1 Q6W5P4 3/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14467197 1.00 PIK3CA (0.37) PIK3CAPIK3C3HTR1AHTR2AHTR7
SCHEMBL14354273 0.92 AGTR1 (0.40) PIK3CAPIK3C3HTR6AKT1MTOR
SCHEMBL12333286 0.92 AGTR1 (0.40) PIK3CAPIK3C3HTR6AKT1MTOR
SCHEMBL12333391 0.76 CYP11B1 (0.33) PIK3CAPIK3C3AKT1AGTR1CYP11B1
SCHEMBL12333120 0.75 HTT (0.40) PIK3CAPIK3C3HTR6AKT1MTOR
SCHEMBL29277557 0.70 AGTR1 (0.49) PIK3CAHTR1AHTR2AHTR7HTR6
SCHEMBL12333390 0.69 PIK3CD (0.44) PIK3CAHTR6AKT1MTORAGTR1
SCHEMBL27892301 0.68 KMO (0.49) HTR1AHTR2AHTR7HTR6AURKA
SCHEMBL21870386 0.67 ESR1 (0.41) NPC1RAB9AIDO1TDO2
SCHEMBL22549302 0.65 ESR1 (0.51) NPC1RAB9AIDO1TDO2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130005979-A1 THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME KURARAY CO. LTD. (JP) 2013-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005979-A1 THIENOPYRIDINE DERIVATIVE, METHOD FOR PRODUCING SAME AND ORGANIC SEMICONDUCTOR DEVICE USING SAME TPMT, TET1, TYMS PIK3CA 1148/4885PIK3C3 1358/4885HTR1A 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.